What pension research reveals about retirement planning

As the cost of living crisis eases, what steps are you taking to build your pension?

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.1300

-0.0200

(-1.74%)

At close: 04:00PM EDT

1.1100

-0.02

(-1.77%)

After hours:

06:02PM EDT

Currency in USD

Earnings estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	3	3	3	3
Avg. Estimate	-0.06	-0.08	-0.3	-0.33
Low estimate	-0.08	-0.11	-0.37	-0.58
High estimate	-0.03	-0.06	-0.22	0.08
Year ago EPS	-0.06	-0.08	-0.28	-0.3

Revenue estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	3	3	3	3
Avg. Estimate	49.51M	43.58M	180.68M	159.52M
Low estimate	45.79M	41.9M	164.6M	125.9M
High estimate	54M	45.95M	191.06M	184M
Year ago sales	56.38M	42.05M	194.62M	180.68M
Sales growth (year/est)	-12.20%	3.60%	-7.20%	-11.70%

Earnings history	29/06/2023	29/09/2023	30/12/2023	30/03/2024
Est. EPS	-0.02	-0.08	-0.04	-0.08
Actual EPS	-0.06	-0.08	0	-0.09
Difference	-0.04	0	0.04	-0.01
Surprise %	-200.00%	0.00%	100.00%	-12.50%

EPS trend	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.06	-0.08	-0.3	-0.33
7 days ago	-0.06	-0.08	-0.3	-0.33
30 days ago	-0.06	-0.08	-0.29	-0.29
60 days ago	-0.05	-0.08	-0.27	-0.23
90 days ago	-0.06	-0.08	-0.28	-0.08

EPS revisions	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	1	1

Growth estimates	AKBA	Industry	Sector(s)	S&P 500
Current qtr.	N/A	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	-7.10%	N/A	N/A	N/A
Next year	-10.00%	N/A	N/A	N/A
Next 5 years (per annum)	N/A	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A